The HTA Review's final report recommended that consideration be given to allowing the PBAC to conditionalise its recommendations. Why? An analysis reveals the committee is already explicitly conditionalising its recommendations, making them effectively provisional.
We don't need new laws for conditional outcomes, because they are already embedded in the system
August 21, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 22 August
August 22, 2025 - - Podcast -
If companies accept conditional recommendations, they will keep imposing them
August 22, 2025 - - Latest News -
Applications now open for AusBiotech Invest and the Early-Stage Innovation Forum
August 21, 2025 - - Australian Biotech -
Seymour welcomes Medsafe's year-on-year approvals improvement
August 21, 2025 - - Latest News -
We don't need new laws for conditional outcomes, because they are already embedded in the system
August 21, 2025 - - Latest News -
Draft NICE guidance proposes major shake-up of UK diabetes treatment
August 21, 2025 - - Latest News -
The PBAC's 'conditionality' and 'provisional' revolution from 2013 to 2024
August 21, 2025 - - Latest News